Standard BioTools Inc. Common Stock (LAB) — Analysis Summary
Standard BioTools Inc. Common Stock (LAB) has a market cap of $355.02M with year-over-year revenue growth of -51.1%. Net margin stands at -87.8%. The stock trades at a P/E ratio of 4.5.
Key Takeaways
- Revenue changed -51.1% year-over-year
- Net margin of -87.8%
- P/E ratio of 4.5
Compared to other companies in the LABORATORY ANALYTICAL INSTRUMENTS sector, LAB posted revenue growth of -51.1% and trades at a P/E of 4.5.
Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.